We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Versatile Occluder Constricts Peripheral Vasculature

By HospiMedica International staff writers
Posted on 14 Nov 2019
An innovative microcatheter-delivered vascular device provides rapid and focal occlusion of a wide range of peripheral arterial targets.

The Okami Medical (Aliso Viejo, CA, USA) LOw-profile Braided Occluder (LOBO) is a minute embolic device that is designed to occlude a blood vessel by self-expanding when deployed. More...
A unique braiding method that uses wires less than 20 microns in diameter--about ¼ the thickness of a human hair--and a multiple-disk design provide LOBO with a dense-pore scaffold structure that spans the vessel lumen, rapidly reducing flow and accelerating hemostasis in vessels as small as 1.5 mm. Other features include radiopaque marker bands for visualization and instantaneous mechanical detachment.

To provide smooth navigation throughout the peripheral vasculature, the microcatheter-compatible occluder employs a three-disc design that provides excellent trackability in small, tortuous vessels, which allows conformance to curved vessels and focal occlusion. The intuitive, single-click mechanical detachment handpiece allows for precise, instant release of the occluder at the target location and retrievability, if necessary. The device is not indicated for use in blood vessels where crush or bend forces are anticipated, such as in joint areas and superficial vasculature.

“The Okami team brings more than a decade of leadership in braiding technology and minimally invasive vascular solutions,” said Bob Rosenbluth, PhD, President and CEO of Okami Medical. “The LOBO system is uniquely designed to provide a one-and-done solution for many occlusion targets, thus potentially avoiding the need for several embolic devices and enabling more efficient interventions.”

Related Links:
Okami Medical


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.